Finch Therapeutics Group, Inc.
FNCH · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $16 | $21 | $25 | $29 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $0 | $1 | $1 |
| Total Curr. Assets | $17 | $21 | $26 | $30 |
| Property Plant & Equip (Net) | $26 | $27 | $27 | $27 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $2 | $2 | $2 | $2 |
| Tax Assets | $0 | $0 | $16 | $0 |
| Other NC Assets | $0 | $0 | $2 | $0 |
| Total NC Assets | $28 | $29 | $45 | $30 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $46 | $50 | $71 | $59 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $4 | $4 | $3 | $4 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | -$1 | $0 | $1 |
| Total Curr. Liab. | $4 | $3 | $4 | $5 |
| LT Debt | $27 | $28 | $57 | $58 |
| Deferred Rev, NC | $0 | $0 | -$28 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | -$29 |
| Total NC Liab. | $27 | $28 | $28 | $29 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $29 | $30 | $30 | $31 |
| Total Liabilities | $31 | $31 | $48 | $34 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$359 | -$354 | -$350 | -$347 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $373 | $373 | $373 | $373 |
| Total Equity | $14 | $19 | $23 | $26 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $46 | $50 | $71 | $59 |
| Net Debt | $15 | $11 | $35 | $33 |